Browse Category

NASDAQ:HQY News 9 January 2026 - 12 January 2026

HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

New York, Jan 12, 2026, 15:31 EST — Regular session Shares of HealthEquity dropped roughly 10% in Monday afternoon trading following the benefits administrator’s cautious initial fiscal 2027 outlook. The stock last traded down $9.53 at $84.62, hitting a session low around $84.51. This move is significant since HealthEquity’s longer-term targets often set the valuation benchmark for HSA custodians, whose…
HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

HealthEquity stock slides after Goldman Sachs downgrade; HQY earnings watch shifts to March

New York, Jan 9, 2026, 14:28 EST — Regular session Shares of Nasdaq-listed HealthEquity (HQY) fell 2.9% to $95.64 in afternoon trade on Friday after Goldman Sachs cut its rating to sell from neutral and set an $89 price target. The stock hit a session low of $92.97 before it pared some of the drop. (GuruFocus) The downgrade lands at…

Stock Market Today

  • E.l.f. Beauty Stock Down 40%: A Buying Opportunity Amid Growth and Expansion
    January 25, 2026, 4:54 AM EST. E.l.f. Beauty's stock has dropped about 40% from recent highs but shows a strong long-term outlook. The company, known for affordable cosmetics via a fast-follower strategy and influencer marketing, continues to gain market share against incumbents. Its acquisition of premium skincare brand Rhode, founded by Hailey Bieber, positions e.l.f. for new growth opportunities, including expansion into high-end stores like Sephora. Despite revenue growth stalling due to headwinds like tariffs and inventory issues, e.l.f. reports solid underlying brand consumption, especially in U.S. and international markets. The firm's conservative guidance and expansion into outlets like Dollar General and Walmart suggest room for upside. Investors may find value buying the dip amid e.l.f.'s evolving strategy and market positioning.
Go toTop